The use of mutation screening of BRCA1 and BRCA2 genes as a genetic test is still to a certain extent limited and the oncogeneticist may want to use complementary approaches to identify at-risk individuals. In a series of 23 families with at least three breast or ovarian cancer cases, screened for m
Is hereditary site-specific ovarian cancer a distinct genetic condition?
โ Scribed by Liede, Alexander; Tonin, Patricia N.; Sun, Chia Chia; Serruya, Corinne; Daly, Mary B.; Narod, Steven A.; Foulkes, William D.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 14 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0148-7299
- DOI
- 10.1002/(sici)1096-8628(19980106)75:1<55::aid-ajmg12>3.0.co;2-r
No coin nor oath required. For personal study only.
โฆ Synopsis
It is not clear if hereditary site-specific ovarian cancer exists as a genetic entity distinct from the hereditary breast-ovarian cancer syndrome. We have identified a large Ashkenazi Jewish kindred with 8 cases of ovarian carcinoma and no cases of breast cancer. Initially, linkage analysis for this kindred generated a negative LOD score to BRCA1, but subsequent mutation and haplotype analysis of key individuals demonstrated a BRCA1 185delAG mutation segregating with all but 1 of the ovarian cancer cases. This observation has important implications for genetic counselling of families with site-specific ovarian cancer. Hereditary site-specific ovarian cancer is likely to be a variant of the hereditary breastovarian cancer syndrome, attributable to either BRCA1 or BRCA2. We consider women from these families to be at increased risk of breast cancer and counsel them accordingly. Am.
๐ SIMILAR VOLUMES
A new species threatens war. Only an old enemy can stop them. ITF Director Bill Taggart is losing control of the new planet. But more troubling than those threatening to disband the peace treaty is a group of genetically altered super humans. After eight years spent in isolation, the group, compose
The identification of BRCA1 and BRCA2, two breast-ovarian cancer susceptibility genes, has brought many ethical and social issues to the forefront. This paper presents the results of a survey assessing the attitudes of 238 unaffected first-degree relatives of women with breast or ovarian cancer rega